Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ezzat

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Cancer|January 1, 1993
Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumorS Ezzat, C Ezrin, S Yamashita, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 26, 2001
Longitudinal assessment of economic burden and clinical outcomes in acromegalyL S Wilson, J L Shin, S Ezzat
The Journal of Clinical Endocrinology and Metabolism|February 1, 1996
Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressivenessV K LeRiche, S L Asa, S Ezzat
Endocrinology|February 1, 1991
Growth hormone regulation in primary fetal and neonatal rat pituitary cell cultures: the role of thyroid hormoneS Ezzat, D Laks, J Oster, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1997
Altered expression of fibroblast growth factor receptors in human pituitary adenomasS A Abbass, S L Asa, S Ezzat
Journal of Clinical Pharmacology|January 1, 1995
Continuous versus intermittent subcutaneous infusion of octreotide in the treatment of acromegalyA G Harris, S P Kokoris, S Ezzat
European Journal of Endocrinology|June 1, 1994
Effect of octreotide on glucose tolerance in acromegalyB L Koop, A G Harris, S Ezzat
Archives of Pathology & Laboratory Medicine|May 1, 1994
Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphologic studyK Kovacs, L Stefaneanu, S Ezzat, et al.
Biochemical and Biophysical Research Communications|September 11, 2001
A soluble dominant negative fibroblast growth factor receptor 4 isoform in human MCF-7 breast cancer cellsS Ezzat, L Zheng, S Yu, et al.
Bollettino Chimico Farmaceutico|September 26, 2001
Preparation and antibacterial evaluation of some nitrone derivative and their zirconium (IV) chloride complexesK I Khallow, K D Sulayman, S S Ezzat
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Cancer|January 1, 1993
Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumorS Ezzat, C Ezrin, S Yamashita, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 26, 2001
Longitudinal assessment of economic burden and clinical outcomes in acromegalyL S Wilson, J L Shin, S Ezzat
The Journal of Clinical Endocrinology and Metabolism|February 1, 1996
Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressivenessV K LeRiche, S L Asa, S Ezzat
Endocrinology|February 1, 1991
Growth hormone regulation in primary fetal and neonatal rat pituitary cell cultures: the role of thyroid hormoneS Ezzat, D Laks, J Oster, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1997
Altered expression of fibroblast growth factor receptors in human pituitary adenomasS A Abbass, S L Asa, S Ezzat
Journal of Clinical Pharmacology|January 1, 1995
Continuous versus intermittent subcutaneous infusion of octreotide in the treatment of acromegalyA G Harris, S P Kokoris, S Ezzat
European Journal of Endocrinology|June 1, 1994
Effect of octreotide on glucose tolerance in acromegalyB L Koop, A G Harris, S Ezzat
Archives of Pathology & Laboratory Medicine|May 1, 1994
Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphologic studyK Kovacs, L Stefaneanu, S Ezzat, et al.
Biochemical and Biophysical Research Communications|September 11, 2001
A soluble dominant negative fibroblast growth factor receptor 4 isoform in human MCF-7 breast cancer cellsS Ezzat, L Zheng, S Yu, et al.
Bollettino Chimico Farmaceutico|September 26, 2001
Preparation and antibacterial evaluation of some nitrone derivative and their zirconium (IV) chloride complexesK I Khallow, K D Sulayman, S S Ezzat
Pageof 11